Gossamer Bio Inc (NASDAQ: GOSS) has seen a decline in its stock price by -0.10 in relation to its previous close of 0.82. However, the company has experienced a -17.98% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-03-07 that Gossamer Bio, Inc. (GOSS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GOSS’s 50-day simple moving average broke out above its 200-day moving average; this is known as a “golden cross.
Is It Worth Investing in Gossamer Bio Inc (NASDAQ: GOSS) Right Now?
The stock has a 36-month beta value of 1.80. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GOSS is 188.87M, and at present, short sellers hold a 5.70% of that float. On April 18, 2024, the average trading volume of GOSS was 1.29M shares.
GOSS’s Market Performance
GOSS’s stock has seen a -17.98% decrease for the week, with a -40.58% drop in the past month and a -6.22% fall in the past quarter. The volatility ratio for the week is 8.37%, and the volatility levels for the past 30 days are at 8.03% for Gossamer Bio Inc The simple moving average for the past 20 days is -27.28% for GOSS’s stock, with a -17.89% simple moving average for the past 200 days.
Analysts’ Opinion of GOSS
Many brokerage firms have already submitted their reports for GOSS stocks, with Wedbush repeating the rating for GOSS by listing it as a “Outperform.” The predicted price for GOSS in the upcoming period, according to Wedbush is $4 based on the research report published on April 05, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see GOSS reach a price target of $1.25, previously predicting the price at $8. The rating they have provided for GOSS stocks is “Neutral” according to the report published on July 27th, 2023.
GOSS Trading at -30.43% from the 50-Day Moving Average
After a stumble in the market that brought GOSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.38% of loss for the given period.
Volatility was left at 8.03%, however, over the last 30 days, the volatility rate increased by 8.37%, as shares sank -41.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.60% lower at present.
During the last 5 trading sessions, GOSS fell by -17.98%, which changed the moving average for the period of 200-days by -31.67% in comparison to the 20-day moving average, which settled at $1.0991. In addition, Gossamer Bio Inc saw -10.14% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GOSS starting from Hasnain Faheem, who sale 23,172 shares at the price of $1.16 back on Mar 27 ’24. After this action, Hasnain Faheem now owns 120,293 shares of Gossamer Bio Inc, valued at $26,773 using the latest closing price.
Giraudo Bryan, the COO/CFO of Gossamer Bio Inc, sale 6,430 shares at $1.16 during a trade that took place back on Mar 27 ’24, which means that Giraudo Bryan is holding 92,737 shares at $7,431 based on the most recent closing price.
Stock Fundamentals for GOSS
The total capital return value is set at -0.67. Equity return is now at value -480.50, with -61.54 for asset returns.
Based on Gossamer Bio Inc (GOSS), the company’s capital structure generated 0.77 points at debt to capital in total, while cash flow to debt ratio is standing at -0.75. The debt to equity ratio resting at 3.38. The interest coverage ratio of the stock is -12.86.
Currently, EBITDA for the company is -169.37 million with net debt to EBITDA at -1.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.94.
Conclusion
To sum up, Gossamer Bio Inc (GOSS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
